JuveLook Volume

JuveLook Volume: Premium Deep Volumizing Filler for Structural Facial Restoration

JuveLook Volume, manufactured by **A.M.I. (Advanced Medical Ingredients)**, is a **highly cohesive, monophasic, non-animal stabilized hyaluronic acid (NASHA) dermal filler** specifically engineered for **profound structural volumization** and **lifting of deep facial contours**. Presented in a **1.0 ml prefilled syringe**, this variant typically contains **integrated 0.3% lidocaine** for enhanced patient comfort. It targets areas requiring significant volume restoration and projection, utilizing advanced rheology for long-lasting, natural-looking rejuvenation of the facial architecture.https://skin-reboot.com/

**Core Technology & Properties:**
* **Premixed Monophasic NASHA Gel:** Features a homogeneous, highly cross-linked HA matrix for predictable integration and stability.
* **Integrated 0.3% Lidocaine:** Reduces injection discomfort significantly.
* **High Cohesivity:** Designed for exceptional **lifting capacity** and **structural support**, minimizing the risk of migration or spread. Provides strong projection.
* **High G-Prime (Elasticity):** Exhibits significant resistance to deformation under pressure, enabling it to lift sagging tissues and maintain shape effectively in deep layers.
* **High Viscosity:** Thicker consistency facilitates precise placement and bolus formation for volumizing effect.
* **Controlled Particle Size:** Optimized larger particle size (~1000+ µm range) ensures durability and lift in deep tissue planes.

**Mechanism of Action:**
1. **Structural Restoration:** Upon injection into deep facial planes (supraperiosteal, subcutaneous), the high-cohesivity gel creates immediate projection and volume, lifting sagging tissues.
2. **Contour Definition & Projection:** Restores lost facial volume, enhancing definition in the midface (cheeks), lower face (jawline, chin), and temples.
3. **Hydration:** HA attracts and binds water, improving tissue hydration.
4. **Biostimulation:** Stimulates surrounding fibroblasts, promoting gradual collagen and elastin production for sustained tissue quality.
5. **Anesthesia:** Lidocaine provides immediate local pain relief during injection.

**Primary Indications:**
* **Midface Volumization:** Augmenting and lifting cheekbones, restoring malar volume, correcting deep malar hollows.
* **Jawline Definition & Contouring:** Enhancing mandibular angle and body projection, improving lower face shape.
* **Chin Augmentation:** Adding anterior projection and improving profile balance.
* **Temporal Hollowing:** Restoring volume to the sunken temple region.
* **Deep Volume Loss Correction:** Addressing significant age-related atrophy in key structural areas.
* **Facial Rebalancing & Projection:** Enhancing overall facial harmony and profile aesthetics.

**Key Administration Considerations:**
* **Ready-to-Use:** No reconstitution required. Prime syringe carefully.
* **Anesthesia:** Topical numbing cream recommended adjunctively for sensitive patients/areas.
* **Technique:** Primarily suited for **bolus/depot placement**:
* **Needles:** Sharp needles (e.g., 25-27G) for precise supraperiosteal injection.
* **Cannulas:** Highly compatible with blunt microcannulas (e.g., 22-25G, 50mm+) for deep subcutaneous/sub-SMAS placement, potentially reducing vascular risks and bruising.
* **Depth:** **Deep subcutaneous tissue, supraperiosteal plane, or sub-SMAS layer.** *Avoid superficial injection.*
* **Volume:** Typically requires larger boluses (e.g., 0.2-0.5ml per point) compared to finer fillers. Gradual build-up recommended.
* **Post-Treatment:** Expect significant **swelling** (can last several days), redness, tenderness, and potential bruising. Avoid pressure/massage on deep volumized areas.
* **Longevity:** Designed for **long-lasting results**, typically **12-18 months** or more, due to high HA concentration, cross-linking density, and deep placement.
* **Safety:** Standard filler risks: Swelling, bruising, redness, nodules, infection, hypersensitivity (incl. lidocaine). **Critical Risk:** **Vascular occlusion** is possible due to deep placement; necessitates **expert anatomical knowledge**, aspiration, and preference for cannulas. Risk of visible nodules if placed too superficially or overcorrected. Tyndall effect unlikely at correct depth.
* **Regulatory Status:** **CE marked** (Europe/international). **Not FDA-approved in the USA.**
* **Prescription:** Prescription medical device.

JuveLook Volume delivers powerful, enduring structural rejuvenation for patients with significant volume loss, utilizing high-cohesivity monophasic HA technology and integrated lidocaine to restore youthful facial projection and contours safely and effectively.CONTACT US